Financing
Debt Issuance Costs
Moderna Debt Issuance Costs remained flat by 0.0% to $5.50M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 20, 2026
How to read this metric
Higher costs relative to issuance volume may indicate less favorable financing terms or complex debt structures.
Detailed definition
Captures the cash fees and expenses paid to underwriters, legal counsel, and other parties associated with issuing new d...
Peer comparison
Standard administrative cost associated with capital market activities.
Metric ID:
payment_of_debt_issuance_costsHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | $22.00M |
Range$0.00 – $22.00M
Debt Issuance Costs at Other Companies
Frequently Asked Questions
- What is Moderna's debt issuance costs?
- Moderna (MRNA) reported debt issuance costs of $5.50M in Q4 2025.
- What does debt issuance costs mean?
- Cash paid for fees associated with issuing new debt.